Search

Search Constraints

You searched for: Author/Creator Hanamura, Ichiro

Search Results

1. A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival. (28th July 2021)

2. Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells. Issue 5 (9th April 2020)

3. Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma. Issue 5 (17th April 2018)

5. Cytopenia associated with copper deficiency. Issue 4 (26th August 2021)

6. EBV‐positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases. Issue 1 (7th January 2019)

7. Establishment and characterization of a novel vincristine‐resistant diffuse large B‐cell lymphoma cell line containing the 8q24 homogeneously staining region. Issue 12 (20th November 2018)

8. Establishment and characterization of CRISPR/Cas9‐mediated NF2−/− human mesothelial cell line: Molecular insight into fibroblast growth factor receptor 2 in malignant pleural mesothelioma. Issue 1 (14th December 2018)

9. Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10). Issue 2 (8th October 2020)

10. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022)